Protocol No
IIT-HAMADANI-FLU-MEL-TBI
Principal Investigator
Mehdi Hamadani
Phase
II
Summary
To find out the safety and tolerability of reduced intensity
conditioning (RIC) consisting of Propyhlene Glycol-Free Melphalan HCI (EVOMELA) in
combination with Fludarabine and Total Body Irradiation (TBI) for subjects undergoing
Haplo Identical (which involves matching your tissue type with a related or unrelated
donor) Hematopoietic Cell Transplantation (Haplo-HCT).
Description
EVOMELA In Combination With Fludarabine and TBI based reduced intensity conditioning for Haplo BMT
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Sub Category
ClinicalTrials.gov